1 / 1

Thalidomide-Based Regimens and VTE Rates in Newly Diagnosed Multiple Myeloma Patients

This study investigates the incidence of venous thromboembolism (VTE) in patients with newly diagnosed multiple myeloma (MM) receiving thalidomide-based therapies. The research highlights the risks associated with thalidomide, scrutinizing the correlation between treatment regimens and the development of VTE. Analyzing a cohort of 1090 patients, the findings emphasize the need for vigilant VTE monitoring and prophylaxis strategies during thalidomide treatment to improve patient outcomes and safety.

adanne
Télécharger la présentation

Thalidomide-Based Regimens and VTE Rates in Newly Diagnosed Multiple Myeloma Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Thalidomide-based Regimens: Rates of VTE* in Newly Diagnosed MM 1090

More Related